Stable Angina
📧 Sign up to get email alerts when something new happens for Stable Angina.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Boston Scientific COMET Wire Validation Study [NA]
Clinical trial update for the COMET Wire Validation Study sponsored by University Hospital Southampton NHS Foundation Trust; the study in st…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome [NA]
This entry reports a completed clinical trial evaluating the incremental value of point-of-care heart-type fatty acid-binding protein (H-FAB…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent [NA]
A clinical trial comparing the CGBIO Stent to the Biomatrix Flex Stent is being conducted to evaluate safety and efficacy; the current statu…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values [NA]
This completed clinical trial evaluated grey-zone fractional flow reserve in patients with stable intermediate coronary lesions to assess it…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
Observational study to evaluate the safety of DILATREND SR Capsule in Korean patients with essential hypertension, chronic stable angina, an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials [Phase 4]
Phase 4 COSTA trials evaluating the COMBO-Stent in patients on chronic anticoagulation have been withdrawn.
-
FDA approval · 2017-01-23FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) from Bausch Health US LLC under NDA 020062, allowing c…
-
FDA approval · 2017-01-04FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for amlodipine besylate from Unichem Pharmaceuticals (USA), Inc.
-
FDA label_change · 2016-11-18FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Danhong Injection in the Treatment of Chronic Stable Angina [Phase 4]
A Phase 4 clinical trial evaluating Danhong Injection for chronic stable angina has been completed.
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography
A completed study evaluated vascular inflammation imaging using a somatostatin receptor PET tracer in patients with cardiovascular and cereb…
-
CLINICAL_TRIALS research · 2016-08-18Clinical Trial Update: BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
Post-market BMX Alpha Registry is monitoring outcomes in patients with coronary disease and ischemic conditions after BioMatrix Alpha stent …
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents [Phase 4]
Phase 4 trial update evaluating neointimal coverage after implantation of a Biolimus-eluting stent with biodegradable polymer. The study use…
-
FDA approval · 2016-07-11FDA Approved: AMLODIPINE BESYLATE — Original Application (POLYGEN PHARMACEUTICALS INC.)
FDA approved the original application for amlodipine besylate by Polygen Pharmaceuticals Inc., broadening access to a generic calcium channe…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Comparison of Saphenous Vein Graft Harvested From Upper Versus Lower Leg in Coronary Artery Bypass Grafting [NA]
A completed clinical trial comparing saphenous vein grafts harvested from the upper versus lower leg in coronary artery bypass grafting to a…
-
FDA label_change · 2016-06-29FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA has approved a supplemental application for Cardizem CD (diltiazem hydrochloride) filed by Bausch Health US LLC under NDA 020062.
-
CLINICAL_TRIALS withdrawal · 2016-05-24Clinical Trial Update: A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia. [Phase 4]
A Phase 4 trial evaluating azilsartan on coronary artery plaque in patients with essential hypertension, stable angina, and dyslipidemia has…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent [Phase 4]
A Phase 4 trial comparing the angiographic outcomes of the Orsiro Hybrid Stent versus the Resolute Integrity Stent in patients with coronary…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina [Phase 4]
A Phase 4 clinical trial evaluating nicorandil in patients with stable angina due to coronary heart disease has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina [Phase 4]
Phase 4 trial evaluating febuxostat's effect on coronary artery endothelial function in chronic stable angina. Results were posted in 2016.
-
FDA approval · 2016-01-19FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for amlodipine besylate from Unichem Pharmaceuticals (USA), Inc. to bring a generic product to marke…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: A Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial [Phase 3]
A completed Phase 3 trial comparing everolimus-eluting stents and paclitaxel-eluting stents for coronary revascularization in patients with …
-
FDA approval · 2015-12-21FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc., effectively approving a generic formulation of amlodipi…
-
FDA approval · 2015-12-10FDA Approved: AMLODIPINE BESYLATE — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approves the Original Application for amlodipine besylate, a generic version of the calcium channel blocker used to treat hypertension a…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: United Coronary Biobanks
The update notes that the United Coronary Biobanks trial, sponsored by UMC Utrecht, related to coronary artery disease and acute coronary sy…